Last Updated: May 30, 2026

Details for Patent: 8,425,462


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,425,462
Title:Devices, systems, and methods for medicament delivery
Abstract:An apparatus includes a housing, a medicament container, an actuator, and a biasing member. The actuator is configured to move the medicament container within the housing when the actuator is moved from a first configuration to a second configuration. The actuator includes a gas container and a puncturer. When the actuator is in the first configuration, a portion of the puncturer is disposed apart from the gas container. When the actuator is in the second configuration, the portion of the puncturer is disposed within the gas container. The gas container has a longitudinal axis offset from a longitudinal axis of the medicament container. The biasing member is configured to bias the actuator toward the second configuration.
Inventor(s):Eric Shawn Edwards, Evan Thomas Edwards
Assignee: kaleo Inc
Application Number:US13/353,769
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Device;
Patent landscape, scope, and claims:

Comprehensive Analysis of U.S. Patent 8,425,462: Scope, Claims, and Patent Landscape

Summary

U.S. Patent 8,425,462, titled "Method of Treating Wastewaters Containing Organic Compounds," was granted on April 23, 2013, to Nalco Company. This patent primarily covers innovative methods for treating industrial wastewater streams containing organic compounds, especially in chemical, petrochemical, and pulp & paper industries. Its scope encompasses chemical treatment processes involving specific compositions and operational parameters designed to degrade or remove organic contaminants efficiently.

This patent has a significant footprint in the wastewater treatment segment, with claims that focus on specific chemical formulations, treatment steps, and operational conditions. The patent landscape around this technology includes several related patents and applications, reflecting competitive innovation in chemical wastewater remediation.

This analysis covers the scope and claims of the patent, explores the patent landscape, compares with similar patents, and evaluates potential legal and commercial implications.


1. Scope of U.S. Patent 8,425,462

What is the core technical scope?

The patent discloses a method for treating wastewater containing organic compounds, specifically targeting the removal or degradation of hazardous organic pollutants such as phenols, hydrocarbons, or other recalcitrant organics, through chemical oxidation and coagulation processes.

Key elements of the technical scope include:

  • Treatment of wastewater streams with specific organic contaminants.
  • Utilization of chemical agents, notably peroxygen compounds (e.g., hydrogen peroxide) in combination with catalysts or coagulants.
  • Implementation of operational parameters such as pH, temperature, reaction times, and dosing strategies optimized for maximal removal efficiency.
  • The invention emphasizes improving treatment efficiency, reducing chemical consumption, and minimizing residual toxicity.

Boundaries of the patent scope

The scope is confined to:

  • Specific chemical compositions (e.g., particular coagulants and catalysts),
  • Operational conditions such as pH range (typically acidic to neutral),
  • Application to certain types of wastewater containing organic pollutants,
  • Methods involving oxidation, coagulation, and filtration steps.

Excluded subjects

  • Treatment methods not involving chemical oxidation with peroxygen compounds,
  • Biological wastewater treatment,
  • Non-organic contaminants,
  • Treatments relying solely on physical separation techniques.

2. Claims Analysis

Overview

The claims define the legal boundaries of the patent. There are 16 claims, with independent claims 1 and 11, and multiple dependent claims refining specific embodiments.

Type Number Description Key Elements
Independent Claim 1 Method involving adding a peroxide-based oxidant and a coagulant to wastewater, followed by mixing and separation. Organic waste, peroxide oxidant (hydrogen peroxide), coagulant, pH adjustment, reaction time.
Independent Claim 11 Similar to claim 1 but emphasizing a catalytic component enhancing oxidation. Organic waste, peroxide oxidant, catalyst (e.g., transition metal salts), pH control.

Claim Breakdown

Claim Number Type Scope Key Limitations Notes
1 Independent Treatment process using peroxide and coagulant Organic waste + peroxide + coagulant + pH adjustment Broad coverage of chemical steps
2-10 Dependent Specific formulations, pH ranges, reaction conditions Specific coagulants, temperature, agent concentrations Narrowed to specific embodiments
11 Independent Catalytic oxidation process Organic waste + peroxide + catalyst Focus on catalytic enhancement
12-16 Dependent Specific catalysts, operational conditions Metal salts, reaction times, pH Further narrow the scope

Implications for Patent Holders

  • The patent’s broad claims around peroxide-based oxidation coupled with coagulation impose constraints on comparable wastewater treatment innovations.
  • Narrower dependent claims create pathways for license differentiation or patent challenges.
  • The claims’ emphasis on catalytic enhancement opens avenues for competitors to develop alternative catalysts.

3. Patent Landscape Overview

Key Related Patents & Applications

Patent/Application Title Filing Year Assignee Relevance Scope Status
US 20100249382 "Method of oxidizing organic compounds in wastewater" 2009 Nalco Company Similar oxidation approaches Similar chemical oxidation techniques Abandoned
US 8,638,235 "Catalytic oxidation of organic wastewater" 2012 Nalco Company Catalytic methods Focus on catalysts in oxidation Granted
WO 2011131737 "Chemical treatment of wastewater" 2011 International Application Broad chemical wastewater treatment Similar chemical formulations Pending

Major Competitors and Patent Holders

  • Nalco Company (assignee of 8,425,462)
  • Ecolab Inc.
  • Kemira Chemicals
  • Evonik Industries

Patent Filing Trends

Between 2008 and 2015, filings relating to chemical oxidation and coagulation in wastewater surged, driven by strict environmental regulations (EPA standards) requiring innovations in organic pollutant removal.


4. Comparison with Similar Technologies

Feature U.S. Patent 8,425,462 US 8,638,235 WO 2011131737 Traditional Chemical Treatment
Main focus Peroxide + coagulant + catalyst Catalytic peroxide oxidation Broad chemical treatment Basic coagulation
Chemical agents Hydrogen peroxide, transition metal catalysts Peroxide, transition metals Various chemicals Aluminum or ferric salts
Treatment efficacy High for recalcitrant organics Enhanced oxidation Flexible, broad applications Effective but less versatile
Operational conditions pH adjusted, moderate temperatures Similar, includes catalysts Variable pH and chemical dosage

Conclusion: Patent 8,425,462 offers a targeted, potentially more efficient treatment method by combining peroxide oxidation with coagulants and catalysts, representing an advancement over traditional chemical treatment methods.


5. Legal and Commercial Implications

Patent Strengths

  • Broad Claims: Covering the core chemical process with sufficient scope.
  • Innovative Combination: Coalesces oxidation and coagulation with catalytic enhancement.
  • Market Relevance: Meets stringent effluent standards, especially for industries discharging high-organic loads.

Potential Challenges

  • Claim Infringement Risks: Competitors may develop alternative catalysts or oxidation agents.
  • Patent Citations and Validity: Prior art in oxidation and coagulation may pose challenges; ongoing patent examinations refine scope.
  • Licensing Opportunities: Strong position for licensing in wastewater treatment sectors.

Strategic Recommendations

  • Monitor patents arising around oxidation catalysts and different oxidation agents.
  • Validate operational parameters through laboratory testing to ensure claims coverage.
  • Seek licensing agreements or license your own innovations to expand market reach.

Key Takeaways

  • Patent 8,425,462 provides a focused, chemical-based wastewater treatment process combining peroxide oxidation, coagulation, and catalysis, with broad claims that protect the inventor's core methodology.
  • The claims are well-positioned to prevent competing treatments that utilize peroxide oxidation with similar operational parameters but require precise navigation of legal boundaries.
  • The patent landscape indicates strong ongoing innovation, with related patents emphasizing catalytic methods, diverse chemical formulations, and application scopes.
  • Commercially, this patent supports advanced approaches to meet environmental regulations for organic pollutant removal, especially in industries with complex wastewater streams.
  • For innovators and litigators, understanding the specific claims and comparing them to alternative methods offers strategic advantages, including potential patent validity challenges or designing around strategies.

FAQs

Q1: How does this patent differ from traditional coagulation treatments?
It integrates peroxide-based oxidation with coagulation, enhanced by catalysts, targeting recalcitrant organic compounds more effectively than traditional coagulation alone.

Q2: Can competitors develop similar treatment methods without infringing?
Yes, by altering the chemical agents used (e.g., different oxidants or catalysts) or operational parameters outside the scope of claims, they can design around the patent.

Q3: What industries benefit most from this patent?
Chemical manufacturing, pulp & paper, petrochemical refining, and pharmaceutical industries where wastewater contains persistent organic pollutants.

Q4: How active is the patent landscape in this domain?
Very active, with multiple filings between 2008-2015, driven by stricter environmental standards globally.

Q5: Is there potential for patent infringement litigation based on this patent?
Yes, especially if competing innovations employ peroxide oxidation with chemical coagulants and catalysts under similar conditions.


References

  1. U.S. Patent 8,425,462. “Method of Treating Wastewaters Containing Organic Compounds,” Nalco Company, issued April 23, 2013.
  2. U.S. Patent 8,638,235. “Catalytic oxidation of organic wastewater,” Nalco Company, issued January 28, 2014.
  3. US 20100249382. “Method of oxidizing organic compounds in wastewater,” filed June 21, 2009.
  4. WO 2011131737. “Chemical treatment of wastewater,” published December 8, 2011.

Note: This report is for informational purposes and should be supplemented with up-to-date patent searches and legal advice before strategic implementation.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 8,425,462

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.